Mackenzie Financial Corp Sells 399,410 Shares of HealthEquity, Inc. $HQY

Mackenzie Financial Corp lessened its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 24.0% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,267,168 shares of the company’s stock after selling 399,410 shares during the quarter. Mackenzie Financial Corp owned about 1.47% of HealthEquity worth $132,749,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in HQY. Skandinaviska Enskilda Banken AB publ boosted its position in shares of HealthEquity by 56.2% in the 2nd quarter. Skandinaviska Enskilda Banken AB publ now owns 1,673 shares of the company’s stock worth $175,000 after purchasing an additional 602 shares in the last quarter. Norges Bank purchased a new position in HealthEquity during the second quarter valued at $75,072,000. Hsbc Holdings PLC boosted its holdings in HealthEquity by 144.8% in the second quarter. Hsbc Holdings PLC now owns 7,561 shares of the company’s stock worth $793,000 after acquiring an additional 4,472 shares in the last quarter. Level Four Advisory Services LLC grew its stake in shares of HealthEquity by 17.5% in the second quarter. Level Four Advisory Services LLC now owns 3,972 shares of the company’s stock worth $416,000 after acquiring an additional 592 shares during the last quarter. Finally, Elevation Point Wealth Partners LLC increased its holdings in shares of HealthEquity by 4.5% during the second quarter. Elevation Point Wealth Partners LLC now owns 3,562 shares of the company’s stock valued at $373,000 after acquiring an additional 152 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

Insider Activity

In related news, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction that occurred on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the completion of the sale, the executive vice president directly owned 49,795 shares in the company, valued at approximately $4,392,416.95. The trade was a 3.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, November 20th. The shares were sold at an average price of $104.56, for a total transaction of $156,840.00. Following the sale, the executive vice president directly owned 75,479 shares of the company’s stock, valued at approximately $7,892,084.24. This represents a 1.95% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 10,781 shares of company stock valued at $1,016,707 in the last ninety days. Insiders own 1.50% of the company’s stock.

HealthEquity Price Performance

NASDAQ HQY opened at $104.58 on Friday. The stock has a market capitalization of $9.01 billion, a price-to-earnings ratio of 63.38, a PEG ratio of 1.36 and a beta of 0.47. HealthEquity, Inc. has a 1-year low of $74.07 and a 1-year high of $116.65. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23. The business’s fifty day moving average price is $96.11 and its 200-day moving average price is $96.84.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, September 2nd. The company reported $0.92 EPS for the quarter, meeting analysts’ consensus estimates of $0.92. HealthEquity had a return on equity of 12.04% and a net margin of 11.49%.The company had revenue of $325.80 million during the quarter, compared to analysts’ expectations of $320.68 million. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. On average, equities analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Analyst Upgrades and Downgrades

HQY has been the topic of a number of analyst reports. JPMorgan Chase & Co. upped their price target on shares of HealthEquity from $125.00 to $126.00 and gave the stock an “overweight” rating in a research note on Wednesday, September 3rd. Wall Street Zen cut shares of HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Weiss Ratings reissued a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, October 8th. KeyCorp lowered their price objective on HealthEquity from $125.00 to $120.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 8th. Finally, BMO Capital Markets started coverage on HealthEquity in a research note on Thursday, November 13th. They set a “market perform” rating and a $100.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $119.00.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.